One in four hepatitis C patients denied initial approval for drug treatment

学びカテゴリーの変更を依頼記事元:

news.yale.edu

2 usersがブックマークコメント

記事へのコメント1件

注目コメント
新着コメント

frothmouth “Nearly one in four patients with chronic hepatitis C (HCV) are denied initial approval for a drug therapy that treats the most common strain of the infection, according to a Yale School of Medicine study.The finding, published Aug. 27 in PLOS ONE, identifies a new barrier to caring for patients w

2015/09/16 リンク

注目コメント算出アルゴリズムの一部にLINEヤフー株式会社の「建設的コメント順位付けモデルAPI」を使用しています

規約違反を報告

いまの話題をアプリでチェック！

バナー広告なし
ミュート機能あり
ダークモード搭載

アプリをダウンロード

One in four hepatitis C patients denied initial approval for drug treatment

One in four hepatitis C patients denied initial approval for drug treatment Nearly one in four pa... One in four hepatitis C patients denied initial approval for drug treatment Nearly one in four patients with chronic hepatitis C (HCV) are denied initial approval for a drug therapy that treats the most common strain of the infection, according to a Yale School of Medicine study. Nearly one in four patients with chronic hepatitis C (HCV) are denied initial approval for a drug therapy that treats t